The global disposable medical device market is projected to reach USD 144.85 billion by 2030, growing from USD 113.95 billion in 2025, at a CAGR of 4.9% during the forecast period (2025–2030).
Market Overview
The demand for disposable medical devices continues to surge, driven by increasing infection control awareness, the rising global burden of chronic diseases, and a growing preference for single-use technologies across hospitals and home healthcare. These devices minimize cross-contamination risks, reduce sterilization costs, and enhance patient safety.
Key market accelerators include:
-
Advancements in biocompatible and sustainable materials
-
Rising surgical and outpatient procedure volumes
-
Expanding elderly population base
-
Government regulations promoting safety and sterility standards
-
Rapid infrastructure development in emerging economies
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=154383032
Key Market Players
Prominent companies operating in this market include:
Johnson & Johnson (US), Baxter (US), BD (US), Cardinal Health, Inc. (US), Abbott (US), Medtronic (Ireland), Solventum (US), Boston Scientific Corporation (US), Stryker Corporation (US), Teleflex Incorporated (US), B. Braun SE (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Merit Medical Systems (US), Alcon Inc. (Switzerland), Medline Industries, Inc. (US), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US), STERIS (US), Integra LifeSciences Holdings Corporation (US), Coloplast (Denmark), Kirwan Surgical Products (US), Owens & Minor, Inc. (US), Aspen Surgical Products (US), and Paul Hartmann AG (Germany).
Recent Strategic Developments
-
Medtronic (July 2025): Extended its long-term partnership with Philips to integrate disposable consumables such as pulse oximetry sensors, capnography lines, and brain monitoring electrodes with Philips’ patient monitoring systems.
-
BD (October 2024): Collaborated with Ypsomed to enhance self-injection solutions for high-viscosity biologic drugs, advancing drug delivery innovation.
-
BD India (April 2024): Introduced the UltraTouch Push-Button Blood Collection Set, designed to reduce needlestick injuries by ~88% and enhance patient comfort.
-
Cardinal Health (November 2024): Acquired Advanced Diabetes Supply Group, strengthening its at-home medical supply business.
Company Snapshots
BD (Becton, Dickinson and Company, US)
BD leads in infection prevention and medication delivery, offering syringes, catheters, blood collection systems, and insulin delivery devices. The company’s emphasis on safety-engineered devices and global manufacturing capabilities ensures broad accessibility and regulatory compliance.
Cardinal Health, Inc. (US)
Cardinal Health’s wide disposable portfolio includes surgical drapes, gowns, gloves, masks, wound dressings, and urological catheters. Its global distribution network and partnerships with healthcare systems strengthen its role in infection control and cost-effective care delivery.
Medtronic (Ireland)
Through its Minimally Invasive Therapies Group (formerly Covidien), Medtronic manufactures single-use surgical instruments, airway management devices, and respiratory disposables. These products are central to infection prevention and efficiency in surgical environments.
Market Structure and Competitive Landscape
The global disposable medical device market is highly fragmented, with the top five players—Johnson & Johnson, BD, Cardinal Health, Abbott, and Medtronic—collectively holding 15–20% of market share.
-
Johnson & Johnson (Ethicon, DePuy Synthes): Leader in disposable surgical products like sutures and staplers.
-
Medline Industries: Dominates in high-volume disposables such as gloves, gowns, and wound care supplies.
-
3M Health Care, B. Braun, and Smith & Nephew: Strengthen the market through innovations in infection prevention, wound care, and infusion therapy.
These key players drive market consolidation, technological innovation, and global accessibility of safe, sterile, and cost-efficient disposable medical devices — ensuring patient safety across hospitals, outpatient centers, and home healthcare.
Conclusion
The shift toward disposable medical technologies represents a major evolution in modern healthcare delivery. As infection control standards tighten and patient safety becomes central to hospital operations, the disposable medical device market is poised for sustainable and innovation-driven growth through 2030.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=154383032